公司简介
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter ...
关联新闻
- Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.
Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal
- Hims & Hers Narrows Sales Outlook
The digital healthcare company narrowed its full-year revenue outlook after third-quarter sales came in lower than expected.
- Hims & Hers narrows 2026 revenue forecast as margins contract
Hims & Hers Health cut its full-year core profit forecast on Monday as higher costs tied to branded weight-loss drugs and international expansion pressured margins.
- Andrew Huberman built a health empire on independent advice. He told us why he's now joining Hims' board.
Andrew Huberman has built one of the internet's most powerful health audiences by translating science into practical advice on sleep, fitness, hormones, supplements, and longevity. Now, the Stanford n...
- Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
As part of the agreement, Hims said it won't compound GLP-1 medications like Zepbound in the future.
- Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement
Hims & Hers stock rises after the company announces an agreement with Eli Lilly to offer the pharma giant's GLP-1s on its consumer platform.
- Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia
Telehealth company Hims & Hers said on Monday it has begun offering branded GLP-1 weight-loss drugs and other treatments to men in Australia as it continues to expand its international business.
- Hims & Hers shares slide as costly weight-loss push squeezes margins
Hims & Hers Health's shares fell nearly 7% in premarket trading on Tuesday, as concerns over shrinking profit margins overshadowed strong subscriber growth and a raised annual revenue forecast.